Healthcare expertise firm Aledade, which works with unbiased main care suppliers to construct tech-enabled accountable care organizations, has acquired AI-enabled value-based care analytics platform Curia.
Earlier than the acquisition, the Maryland-based firm piloted Curia’s expertise, which makes use of AI to foretell the probability of adversarial outcomes, determine threat gaps and goal correct care and engagement applications for sufferers.
The pilot recognized 8,000 sufferers with excessive mortality threat inside two years, and Aledade labored with main care suppliers in its community to enlist these sufferers in a complete superior care planning program.
The acquisition will enable Aledade to make the most of Curia’s AI-based capabilities to develop its knowledge gathering, present extra correct knowledge predictions and assist improve main care workflows.
The general public profit company additionally stated it is added over 450 main care suppliers to its community for 2023, which now contains over 1,500 unbiased main care practices and well being facilities.
“We launched Aledade with the purpose of constructing a healthcare system that works higher for sufferers, practices and all of society,” Dr. Farzad Mostashari, CEO and cofounder of Aledade, stated in a press release. “The workforce at Curia is drawn by that very same mission and our work with them has confirmed that, collectively, we’ll make an actual and lasting impression for the practices we serve and their sufferers.”
THE LARGER TREND
In January 2022, Aledade made its first acquisition, buying Iris Healthcare, an advance care planning options platform, which grew to become a part of Aledade’s well being providers unit dubbed Aledade Care Options.
Months after the acquisition, the corporate introduced it garnered $123 million in a Series E funding round, bringing the startup’s valuation to $3.1 billion. A yr prior, the value-based firm closed a $100 million Series D funding round, and in 2020, on the top of the pandemic, scored $64 million in Series C funding.